CHU [CHINA UNICOM (HONG KONG)] 6-K: (Original Filing)
[2 3]
[FORM 8-K CURRENT REPORT FOR ISSUERS SUBJECT TO THE CURRENT REPORT April 11, 2012 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co., Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]
[FORM 8-K CURRENT REPORT FOR ISSUERS SUBJECT TO THE CURRENT REPORT April 11, 2012 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co., Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]
[SCHEDULE 14A Check the appropriate box: [ ] Preliminary Proxy Statement [X] Definitive Proxy Statement [ ] Definitiveditional Materials JF China Region Fund, _______________________________________ Payment of Filing Fee (Check the appropriate box): [X] No fee required [ ] Feemputed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11]
[April 13, 2012 H. Roger Schwall John Cannarella Mark C. Shannon Division of Corporate Finance 100 F Street, NE Re: PetroChina Company Limited Form 20-F for Fiscal Year Ended December 31, 2010 Filed May 10, 2011 Response Letter Dated November 10, 2011 File No. 1-15006 Dear Mr. Schwall, Mr. Cannarella and Mr. Shannon: Set forth below are the Companys responses]
[April 13, 2012 H. Roger Schwall John Cannarella Mark C. Shannon Division of Corporate Finance 100 F Street, NE Re: PetroChina Company Limited Form 20-F for Fiscal Year Ended December 31, 2010 Filed May 10, 2011 Response Letter Dated November 10, 2011 File No. 1-15006 Dear Mr. Schwall, Mr. Cannarella and Mr. Shannon: Set forth below are the Companys responses]